To assess the correlation between disease stage and the expression levels of PD‐L1 and HLA‐G in NSCLC, specimen collection was carried out in accordance with the Institutional Review Board (IRB) guidelines. This evidence concerns the gene HLA-G and non-small cell lung carcinoma.